| 【Fixed Income Research】China AMCs – Opportunities after the collateral damage |
| 【Company Research】Xtep (1368 HK) – A resilient 2Q22 and FY22E guidance upheld |
| 【Company Research】Maxscend (300782 CH) – 1H22 profit alert: weak 2Q market dragged performance |
| 【Sector Research】China Property Sector – Banks may have to bail out some troubled projects |
| 【Company Research】Innolight (300308 CH) – Data center demand to remain resilient in 2H22 |
| 【Company Research】Anta Sports (2020 HK) – A resilient 2Q22 and a mild inventory concern |
| 【Company Research】Greentown Management (9979 HK) – Surprise again: 1H22 new contracts largely beat |
| 【Company Research】China Meidong Auto (1268 HK) – 1H22 earnings full of noises; StarChase 2H22 key |
| 【Company Research】PA Good Doctor (1833 HK) – 1H22E preview: pandemic hurt topline while second-half outlook remains solid |
| 【Company Research】Q Technology (1478 HK) – 1H profit warning in-line; Trim TP to reflect uncertainty |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
